FGF-23 and the Progression of Coronary Arterial Calcification in Patients New to Dialysis | Zendy

Abigail Khan | Zendy; Julio A. Chirinos | Zendy; Harold Litt | Zendy; Wei Yang | Zendy; Sylvia E. Rosas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

FGF-23 and the Progression of Coronary Arterial Calcification in Patients New to Dialysis

Author(s) -

Abigail Khan,

Julio A. Chirinos,

Harold Litt,

Wei Yang,

Sylvia E. Rosas

Publication year - 2012

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.02160212

Subject(s) - fibroblast growth factor 23 , medicine , agatston score , interquartile range , cardiology , vitamin d and neurology , hemodialysis , dialysis , risk factor , surrogate endpoint , gastroenterology , parathyroid hormone , coronary artery calcium , calcium , coronary artery disease

Fibroblast growth factor 23 (FGF-23), a regulator of phosphorus metabolism, is a risk marker in CKD. FGF-23 has been associated with coronary arterial calcification (CAC), but it is not known whether FGF-23 predicts CAC progression in CKD. The aim of this study was to evaluate the association of FGF-23 with CAC progression in advanced CKD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research